vidarabine has been researched along with African Sleeping Sickness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Koning, HP; Eze, AA; Gustavsson, AL; Hammarström, LG; Lundbäck, T; Olivera, GC; Rottenberg, ME; Sjöberg, B; Svensson, R; Vodnala, SK; Yeheskieli, E | 1 |
| Fijolek, A; Hofer, A; Mäser, P; Mosimann, M; Rofougaran, R; Vodnala, M | 1 |
| Cestari, I; Stuart, K | 1 |
3 other study(ies) available for vidarabine and African Sleeping Sickness
| Article | Year |
|---|---|
Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.
Topics: Animals; Cell Survival; Cells, Cultured; Deoxyadenosines; Dose-Response Relationship, Drug; Humans; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2013 |
Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei.
Topics: Adenine; Adenosine Kinase; Animals; Antimetabolites; Catalysis; Guanosine Triphosphate; Humans; Leishmania donovani; Membrane Transport Proteins; Protozoan Proteins; Recombinant Proteins; Substrate Specificity; Trypanosoma brucei brucei; Trypanosomiasis, African; Vidarabine | 2008 |
Inhibition of isoleucyl-tRNA synthetase as a potential treatment for human African Trypanosomiasis.
Topics: Animals; Blood-Brain Barrier; Disease Models, Animal; Drug Design; Enzyme Inhibitors; Isoleucine-tRNA Ligase; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Recombinant Proteins; RNA Interference; Transfection; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2013 |